337 related articles for article (PubMed ID: 11209044)
1. Can mosaic tumor vessels facilitate molecular diagnosis of cancer?
Folkman J
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):398-400. PubMed ID: 11209044
[No Abstract] [Full Text] [Related]
2. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?
Rafii S; Lyden D; Benezra R; Hattori K; Heissig B
Nat Rev Cancer; 2002 Nov; 2(11):826-35. PubMed ID: 12415253
[No Abstract] [Full Text] [Related]
3. Tumoral vascularity as a prognostic factor in cancer.
Weidner N; Folkman J
Important Adv Oncol; 1996; ():167-90. PubMed ID: 8791135
[No Abstract] [Full Text] [Related]
4. Angiogenesis in multiple myeloma.
Sezer O; Niemöller K; Jakob C; Heider U
Leuk Res; 2002 Jul; 26(7):701-2. PubMed ID: 12008091
[No Abstract] [Full Text] [Related]
5. Cancer: Limitations of therapies exposed.
Casanovas O
Nature; 2012 Apr; 484(7392):44-6. PubMed ID: 22481354
[No Abstract] [Full Text] [Related]
6. [Significance of vascular endothelial growth factor--VEGF--in tumor angiogenesis. Therapeutic possibilities in solid tumors].
Werther K; Nielsen HJ
Ugeskr Laeger; 2000 Sep; 162(37):4916-20. PubMed ID: 11002739
[No Abstract] [Full Text] [Related]
7. Vascular endothelial growth factor as a target for antiangiogenic therapy.
Gordon MS
J Clin Oncol; 2000 Nov; 18(21 Suppl):45S-6S. PubMed ID: 11060326
[No Abstract] [Full Text] [Related]
8. [Tumor angiogenesis].
Ono M; Kuwano M
Seikagaku; 1998 Sep; 70(9):1159-70. PubMed ID: 9796411
[No Abstract] [Full Text] [Related]
9. Anticancer therapy with angiogenesis inhibitors.
Ghilardi C; Bani MR; Giavazzi R
Tumori; 2001; 87(6):S14-6. PubMed ID: 11989610
[No Abstract] [Full Text] [Related]
10. Recent advances in angiogenesis, anti-angiogenesis and vascular targeting.
Bikfalvi A; Bicknell R
Trends Pharmacol Sci; 2002 Dec; 23(12):576-82. PubMed ID: 12457776
[TBL] [Abstract][Full Text] [Related]
11. The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies.
Kuwano M; Uchiumi T; Hayakawa H; Ono M; Wada M; Izumi H; Kohno K
Cancer Sci; 2003 Jan; 94(1):9-14. PubMed ID: 12708467
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis and antiangiogenic therapy.
Sledge GW; Miller KD
Curr Probl Cancer; 2002; 26(1):1-60. PubMed ID: 11961506
[No Abstract] [Full Text] [Related]
13. Use of tumor-activated hepatic stellate cell as a target for the preclinical testing of anti-angiogenic drugs against hepatic tumor development.
Olaso E; Vidal-Vanaclocha F
Methods Mol Med; 2003; 85():79-86. PubMed ID: 12710199
[No Abstract] [Full Text] [Related]
14. Optical imaging and tumor angiogenesis.
Lin PC
J Cell Biochem; 2003 Oct; 90(3):484-91. PubMed ID: 14523982
[TBL] [Abstract][Full Text] [Related]
15. Regulators of angiogenesis as targets for anti-angiogenic tumor therapy.
Breier G; Heidenreich R; Gaumann A; Groot M; Licht A; Nicolaus A; Schmitz J; Reichmann E; Plate KH; Vajkoczy P
Ann Hematol; 2002; 81 Suppl 2():S71-2. PubMed ID: 12611084
[No Abstract] [Full Text] [Related]
16. Angiogenesis and angiogenesis inhibitors in cancer.
Giavazzi R; Taraboletti G
Forum (Genova); 1999; 9(3):261-72. PubMed ID: 10504172
[TBL] [Abstract][Full Text] [Related]
17. Symposium on molecular pathogenesis of respiratory diseases and its clinical implication. 4. Molecular pathogenesis of lung cancer and its molecular targeted therapy.
Sone S; Shinohara T; Nishioka Y; Yano S
Intern Med; 2001 Feb; 40(2):167-70. PubMed ID: 11300157
[No Abstract] [Full Text] [Related]
18. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM
Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447
[TBL] [Abstract][Full Text] [Related]
19. Circulating endothelial cells as a novel marker of angiogenesis.
Mancuso P; Calleri A; Cassi C; Gobbi A; Capillo M; Pruneri G; Martinelli G; Bertolini F
Adv Exp Med Biol; 2003; 522():83-97. PubMed ID: 12674213
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with paclitaxel and thalidomide inhibits angiogenesis and growth of human colon cancer xenograft in mice.
Fujii T; Tachibana M; Dhar DK; Ueda S; Kinugasa S; Yoshimura H; Kohno H; Nagasue N
Anticancer Res; 2003; 23(3B):2405-11. PubMed ID: 12894521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
